Brig-Glis, Switzerland

Barry Jackson

This inventor holds 15 USPTO granted patents and 1 EPO patent, primarily in Organic Chemistry. Top assignees: Lonza Inc., Lonza Ag, Other. Active years: 1977-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barry Jackson. Retrieved from https://idiyas.com/inventor/barry-jackson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 73.3

 

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 96(Granted Patents)


Location History:

  • Visp, CH (1977 - 1989)
  • Glis, CH (1992)
  • Brig/Glis, CH (1997)
  • Schweiz, CH (2006)
  • Brig-Glis, CH (1994 - 2016)

Company Filing History:


Years Active: 1977-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Dioxo Hexanoate Ester
Sodium 3-Hydroxy-3-Methylbutyrate
Geranic Acid Derivatives
Chroman Derivatives
Alkyl Acetoacetates
Imidazolinium Salts
Cyclobutanedione-Bisketals
Squaric Acid
Cyclobuten-1-One Salts
Chloroacetoacetic Acid Amides
Monohaloacetylhalides
Orotic Acid
15 patents (USPTO):Explore Patents

Title: The Innovative Mind of Barry Jackson

Introduction

Barry Jackson, a noteworthy inventor based in Brig-Glis, Switzerland, has made significant contributions to the field of chemistry with a total of 15 patents to his name. His innovative work focuses on various chemical processes, showcasing his inventive spirit and dedication to scientific advancement.

Latest Patents

Among his latest innovations is the patent related to the "Preparation of 3,5-dioxo hexanoate ester in two steps." This invention reveals a method for creating tert-butyl 6-chloro-3,5-dioxohexanoate from a Meldrum's acid derivative. Notably, this compound is utilized in the preparation of several key pharmaceuticals, including tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate (BHA), as well as Rosuvastatin and Atorvastatin. This highlights the practical applications of his research in advancing drug development.

Career Highlights

Barry Jackson has held key roles in reputable companies throughout his career. He has contributed significantly to both Lonza Inc. and Lonza AG, where his expertise in chemistry has been instrumental in driving innovative projects. His work not only reflects his personal achievements but also enhances the capabilities of the organizations he has been a part of.

Collaborations

Throughout his career, Barry has collaborated with fellow professionals such as Thomas Scholl and Christian Noti. These partnerships have enriched his research endeavors and led to collaborative innovations that benefit the wider scientific community.

Conclusion

In summary, Barry Jackson stands out as an exemplary inventor whose contributions have paved the way for advancements in pharmaceutical chemistry. With 15 patents and a commitment to innovation, his work continues to inspire future generations of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…